<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1653">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05139641</url>
  </required_header>
  <id_info>
    <org_study_id>MYBC</org_study_id>
    <nct_id>NCT05139641</nct_id>
  </id_info>
  <brief_title>Multidisciplinary Shared Decision Making of Fertility Preservation in Young Women With Breast Cancer</brief_title>
  <acronym>MYBC</acronym>
  <official_title>Multidisciplinary Shared Decision Making of Fertility Preservation in Young Women With Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MedicalExcellence</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>MedicalExcellence</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multidisciplinary shared decision making of fertility preservation in Young womenwith Breast&#xD;
      Cancer (MYBC): A Pragmatic stepped wedge cluster randomised trial&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">December 2028</completion_date>
  <primary_completion_date type="Anticipated">December 2027</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>selection ratio of fertility preservation procedure</measure>
    <time_frame>selection ratio of fertility preservation procedure from Baseline to six years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The success rate of pregnancy</measure>
    <time_frame>The success rate of pregnancy from Baseline to six years</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">4100</enrollment>
  <condition>Young Womenwith Breast Cancer</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>counseling theraphy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Retrospective data</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Counseling to preserve fertility</intervention_name>
    <description>Counseling to preserve fertility VS Control group</description>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>counseling theraphy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women aged 19 to 40 years old&#xD;
&#xD;
          -  A person diagnosed with breast cancer by biopsy&#xD;
&#xD;
          -  Those who don't have evidence of distant metastasis&#xD;
&#xD;
          -  Eastern Cooperative Oncology Group(ECOG) performance status: 0-2 score&#xD;
&#xD;
          -  Before registering for clinical trials, chemotherapy, radiation therapy, anti-hormone&#xD;
             therapy, immunotherapy, and surgery are not performed&#xD;
&#xD;
          -  A person who has fully understood and listened to the explanation of this clinical&#xD;
             trial and then gave written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Histologically, a person diagnosed with follicular or sarcoma&#xD;
&#xD;
          -  Those with a history of breast cancer (including recurrent breast cancer)&#xD;
&#xD;
          -  A person diagnosed with another cancer before breast cancer&#xD;
&#xD;
          -  A person diagnosed with metastatic breast cancer&#xD;
&#xD;
          -  A person who has a mental illness and has a hard time understanding clinical trials&#xD;
&#xD;
          -  Those who plan to conduct follow-up observation elsewhere(to change of hometowm)&#xD;
&#xD;
          -  Menopausal factors without menstruation after more than a year from the last menstrual&#xD;
             date&#xD;
&#xD;
          -  A pregnant woman&#xD;
&#xD;
          -  Inappropriate for participation in clinical trials&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Minjung Kim</last_name>
    <phone>82-2-3482-7809</phone>
    <email>mj.kim@mediex.co.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical Excellence</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <contact>
      <last_name>Minjung Kim</last_name>
      <email>mj.kim@mediex.co.kr</email>
    </contact>
    <investigator>
      <last_name>Heejeong Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 17, 2021</study_first_submitted>
  <study_first_submitted_qc>November 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 1, 2021</study_first_posted>
  <last_update_submitted>November 17, 2021</last_update_submitted>
  <last_update_submitted_qc>November 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

